Methylphenobarbital: Difference between revisions
CSV import Tags: mobile edit mobile web edit |
CSV import |
||
| Line 1: | Line 1: | ||
{{Short description|An anticonvulsant and sedative drug}} | |||
{{Drugbox | |||
| verifiedfields = changed | |||
| verifiedrevid = 477002123 | |||
| image = Methylphenobarbital.svg | |||
| image_size = 200px | |||
| image_alt = Skeletal formula of methylphenobarbital | |||
}} | |||
'''Methylphenobarbital''', also known as '''mephobarbital''', is a [[barbiturate]] derivative that is primarily used as an [[anticonvulsant]] and [[sedative]]. It is a [[central nervous system]] depressant that works by enhancing the activity of the [[neurotransmitter]] [[gamma-aminobutyric acid]] (GABA) in the brain. | |||
Methylphenobarbital | ==Pharmacology== | ||
Methylphenobarbital is a [[GABA receptor]] agonist, which means it increases the effect of GABA, leading to increased inhibitory effects in the [[central nervous system]]. This action helps to stabilize neuronal activity and prevent [[seizures]]. | |||
== | ==Medical uses== | ||
Methylphenobarbital is primarily used in the treatment of [[epilepsy]], particularly in the management of [[generalized tonic-clonic seizures]] and [[partial seizures]]. It may also be used as a [[sedative]] in certain medical situations. | |||
==Side effects== | |||
Common side effects of methylphenobarbital include [[drowsiness]], [[dizziness]], and [[ataxia]]. Long-term use can lead to [[tolerance]] and [[dependence]]. | |||
==Mechanism of action== | |||
Methylphenobarbital enhances the inhibitory effects of GABA by binding to the [[GABA_A receptor]] and increasing the duration of [[chloride ion]] channel opening, which hyperpolarizes the neuron and reduces neuronal excitability. | |||
==Synthesis and metabolism== | |||
Methylphenobarbital is metabolized in the [[liver]] to [[phenobarbital]], which is also an active anticonvulsant. This conversion contributes to its long duration of action. | |||
== | ==History== | ||
Methylphenobarbital was first synthesized in the early 20th century and has been used clinically for many decades. It was developed as a derivative of [[phenobarbital]] to provide similar anticonvulsant effects with potentially fewer side effects. | |||
==Related pages== | |||
* [[Barbiturate]] | |||
* [[Phenobarbital]] | |||
* [[Anticonvulsant]] | |||
* [[Sedative]] | |||
[[Category:Barbiturates]] | [[Category:Barbiturates]] | ||
[[Category: | [[Category:Anticonvulsants]] | ||
[[Category: | [[Category:Sedatives]] | ||
Revision as of 05:24, 16 February 2025
An anticonvulsant and sedative drug
| Methylphenobarbital | |
|---|---|
| |
| INN | |
| Drug class | |
| Routes of administration | |
| Pregnancy category | |
| Bioavailability | |
| Metabolism | |
| Elimination half-life | |
| Excretion | |
| Legal status | |
| CAS Number | |
| PubChem | |
| DrugBank | |
| ChemSpider | |
| KEGG | |
Methylphenobarbital, also known as mephobarbital, is a barbiturate derivative that is primarily used as an anticonvulsant and sedative. It is a central nervous system depressant that works by enhancing the activity of the neurotransmitter gamma-aminobutyric acid (GABA) in the brain.
Pharmacology
Methylphenobarbital is a GABA receptor agonist, which means it increases the effect of GABA, leading to increased inhibitory effects in the central nervous system. This action helps to stabilize neuronal activity and prevent seizures.
Medical uses
Methylphenobarbital is primarily used in the treatment of epilepsy, particularly in the management of generalized tonic-clonic seizures and partial seizures. It may also be used as a sedative in certain medical situations.
Side effects
Common side effects of methylphenobarbital include drowsiness, dizziness, and ataxia. Long-term use can lead to tolerance and dependence.
Mechanism of action
Methylphenobarbital enhances the inhibitory effects of GABA by binding to the GABA_A receptor and increasing the duration of chloride ion channel opening, which hyperpolarizes the neuron and reduces neuronal excitability.
Synthesis and metabolism
Methylphenobarbital is metabolized in the liver to phenobarbital, which is also an active anticonvulsant. This conversion contributes to its long duration of action.
History
Methylphenobarbital was first synthesized in the early 20th century and has been used clinically for many decades. It was developed as a derivative of phenobarbital to provide similar anticonvulsant effects with potentially fewer side effects.
